Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Merck
MRK
|
+$468M |
| 2 |
Johnson & Johnson
JNJ
|
+$440M |
| 3 |
IBM
IBM
|
+$355M |
| 4 |
Booking.com
BKNG
|
+$332M |
| 5 |
RAI
Reynolds American Inc
RAI
|
+$331M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
LLTC
Linear Technology Corp
LLTC
|
+$482M |
| 2 |
Walt Disney
DIS
|
+$247M |
| 3 |
Visa
V
|
+$219M |
| 4 |
Deere & Co
DE
|
+$200M |
| 5 |
Johnson Controls International
JCI
|
+$179M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 15.02% |
| 2 | Technology | 13.31% |
| 3 | Financials | 12.25% |
| 4 | Industrials | 9.65% |
| 5 | Consumer Staples | 9.54% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
426
Banco Santander Chile
BSAC
$16.3B
| $40.7M | 0.06% |
1,624,527
+375,600
| +30% | +$8.49M |
|
|
PDM
427
Piedmont Realty Trust
PDM
$1.18B
| $40.7M | 0.06% |
1,903,324
-136,376
| -7% | -$2.95M |
|
|
LTXB
428
DELISTED
LegacyTexas Financial Group Inc
LTXB
| $40.7M | 0.06% |
1,019,879
-27,600
| -3% | -$1.15M |
|
|
DOOR
429
DELISTED
MASONITE INTERNATIONAL CORP
DOOR
| $40.6M | 0.06% |
512,737
-74,663
| -13% | -$5.41M |
|
430
Hilton Worldwide
HLT
$72.6B
| $40.4M | 0.06% |
690,700
+617,933
| +849% | +$35.9M |
|
431
Skywest
SKYW
$4.18B
| $40.3M | 0.06% |
1,178,000
+183,900
| +18% | +$6.56M |
|
|
NVMI
432
Nova
NVMI
$12.9B
| $40.3M | 0.06% |
2,168,600
+97,300
| +5% | +$1.55M |
|
|
WNS
433
DELISTED
WNS Holdings
WNS
| $40.3M | 0.06% |
1,408,223
+9,423
| +0.7% | +$267K |
|
434
Delta Air Lines
DAL
$58.9B
| $40.1M | 0.06% |
+872,300
| New | +$42.6M |
|
|
MASI
435
DELISTED
Masimo
MASI
| $40M | 0.06% |
429,100
+255,700
| +147% | +$21.1M |
|
436
MPLX
MPLX
$60.6B
| $39.8M | 0.06% |
1,103,967
-450,300
| -29% | -$16.6M |
|
|
MODV
437
DELISTED
ModivCare
MODV
| $39.8M | 0.06% |
895,700
-14,900
| -2% | -$612K |
|
|
XXIA
438
DELISTED
Ixia
XXIA
| $39.8M | 0.06% |
2,025,720
+349,500
| +21% | +$6.55M |
|
|
SNOW
439
DELISTED
Intrawest Resorts Holdings, Inc.
SNOW
| $39.8M | 0.06% |
1,591,269
+146,000
| +10% | +$3.22M |
|
440
ArcelorMittal
MT
$55.8B
| $39.8M | 0.06% |
1,586,918
+1,201,025
| +311% | +$30.4M |
|
|
DFS
441
DELISTED
Discover Financial Services
DFS
| $39.7M | 0.06% |
+581,100
| New | +$40.8M |
|
442
US Physical Therapy
USPH
$1.22B
| $39.5M | 0.06% |
605,000
+13,300
| +2% | +$943K |
|
443
Colliers International
CIGI
$5.18B
| $39.4M | 0.06% |
835,100
+160,600
| +24% | +$6.86M |
|
444
Albany International
AIN
$1.81B
| $39.4M | 0.06% |
854,500
-11,870
| -1% | -$552K |
|
445
Coherent
COHR
$70B
| $39.3M | 0.05% |
1,090,591
+252,891
| +30% | +$8.93M |
|
446
CMS Energy
CMS
$22B
| $39.3M | 0.05% |
878,700
+809,600
| +1,172% | +$35.1M |
|
|
TIF
447
DELISTED
Tiffany & Co.
TIF
| $39.2M | 0.05% |
+411,400
| New | +$35.1M |
|
|
SEE
448
DELISTED
Sealed Air
SEE
| $39.2M | 0.05% |
899,100
+249,900
| +38% | +$11.7M |
|
449
HEICO Corp Class A
HEI.A
$37.5B
| $39.2M | 0.05% |
1,274,580
+279,785
| +28% | +$8.01M |
|
450
Regency Centers
REG
$13.9B
| $39M | 0.05% |
586,745
-432,855
| -42% | -$29.7M |
|
Similar funds
Jim Simons's Q1 2017 Portfolio in Review
As of Q1 2017, Jim Simons held 3,652 positions worth $71.6B, up 13% from $63.2B the previous quarter. Its ten largest holdings account for 7.9% of the portfolio.
Jim Simons deployed $5.19B of net new capital in Q1 2017, opening 433 new positions and adding to 1,585 existing holdings. Its largest new stake was Merck: 7,716,460 shares worth $468M.
By sector, the portfolio is most concentrated in Healthcare at 15% of assets, up from 12% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was Walt Disney, an estimated $247M trimmed.
- Jim Simons's largest Q1 2017 buy was Merck: 7,716,460 shares worth $468M.
- Jim Simons added most to Johnson & Johnson in Q1 2017, an estimated $440M increase.
- Jim Simons's biggest Q1 2017 reduction was Walt Disney, cutting an estimated $247M.
- Jim Simons fully exited Linear Technology Corp in Q1 2017, selling an estimated $482M.
- Jim Simons's ten largest holdings make up 7.9% of its $71.6B portfolio in Q1 2017.
- Jim Simons opened 433 new positions and closed 462 in Q1 2017.
- Jim Simons's portfolio value rose 13% quarter-over-quarter to $71.6B.
Based on Renaissance Technologies's 13F filing for Q1 2017, filed 12 May 2017.